BDR pharmaceutical company focused on addressing critical unmet medical needs, announced the launch...

BDR pharmaceutical company focused on addressing critical unmet medical needs, announced the launch of Xatronem-AV (aztreonam +avibactam injection) 2 g, an advanced antibacterial therapy developed for the treatment of serious infections caused by multidrug-resistant (MDR) Gram-negative bacteria.
Xatronem av 2gm injection available in Jinomm biotech
call for 7409966555